1998
DOI: 10.1016/s0142-9612(98)00126-4
|View full text |Cite
|
Sign up to set email alerts
|

Study of the effect of polybutylcyanoacrylate nanoparticles and their metabolites on the primary immune response in mice to sheep red blood cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2002
2002
2019
2019

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…For example, if administered intravascularly to the rats, N-butyl-2-cyanoacrylate induces only mild eosinophilic inflammation during the first day and after 7 days the tissue reaction is minimal [38]. However, small particles of cyanoacrylates can modulate immune response to external antigens as demonstrated by Simeonova et al [39]. Currently it is believed that the adjuvant effect of synthetic materials in stimulating dendritic cells and the adaptive immune response to co-expressed (auto)antigens may be more important than was previously thought [40].…”
Section: Issues Of Immune Response To Foreign Proteins and Biomateriamentioning
confidence: 99%
“…For example, if administered intravascularly to the rats, N-butyl-2-cyanoacrylate induces only mild eosinophilic inflammation during the first day and after 7 days the tissue reaction is minimal [38]. However, small particles of cyanoacrylates can modulate immune response to external antigens as demonstrated by Simeonova et al [39]. Currently it is believed that the adjuvant effect of synthetic materials in stimulating dendritic cells and the adaptive immune response to co-expressed (auto)antigens may be more important than was previously thought [40].…”
Section: Issues Of Immune Response To Foreign Proteins and Biomateriamentioning
confidence: 99%
“…1,9,10 Moreover, the toxicity is considered low in the case of multiple dosing (chronic treatment; e.g., LD 50 of poly(isobutylcyanoacrylate) in rats: 242 mg/kg), as the overloading of cells with slowly degrading polyesters is avoided. [11][12][13] In addition, the recovery of cells after the metabolization of the nanoparticles (NPs) takes place easily in vivo due to the considerable low contact time with the degradation products, as they are taken away from their degradation site. 10 Several clinical trials have also highlighted the good tolerance of these drug carriers.…”
Section: Introductionmentioning
confidence: 99%